Diane Simeone begins work as director of Moores Cancer Center on April 1

Project Purple announces research grant to sustain pancreatic cancer studies that have been disrupted by federal funding policy changes

Project Purple, a national nonprofit dedicated to empowering the fight against pancreatic cancer, is launching the Pancreatic Cancer Research Recovery Support Grant. The initiative provides up to two years of bridge or rescue funding for promising pancreatic cancer research projects that were disrupted due to administrative funding policy changes at major federal agencies such as the NIH, the Department of Defense, or the National Science Foundation.

September 26, 2025

Vol.51 No.35

Clinical Roundup

Oral microbes linked to increased risk of pancreatic cancer

Twenty-seven species of bacteria and fungi, among the hundreds that live in people’s mouths, have been collectively tied to a 3.5 times greater risk of developing pancreatic cancer, according to a study led by NYU Langone Health and its Perlmutter Cancer Center.

September 19, 2025

Vol.51 No.34

Clinical Roundup

Researchers identify key enzyme that pancreatic cancer cells need to obtain vital metabolic nutrients

A team of scientists at Sanford Burnham Prebys and the University of Zurich in Switzerland identified a specific phosphoinositide kinase called PI5P4Kα as critical to supporting the unique demands of pancreatic ductal adenocarcinoma cells.

September 19, 2025

Vol.51 No.34

Clinical Roundup

Checkpoint therapy breakthrough sparks new vaccine

Immune-checkpoint therapy, which attempts to harness a patient’s own immune system to fight cancer, has revolutionized cancer care over the past two decades.

September 12, 2025

Vol.51 No.33

Clinical Roundup

Off-the-shelf cancer vaccine elicits strong immune response in patients with pancreatic and colorectal cancer

ELI-002 2P, an off-the-shelf cancer vaccine, can trigger powerful and lasting immune responses, and may help prevent or delay cancer recurrence in high-risk patients whose tumors are driven by KRAS mutations, according to a study published in Nature Medicine.

September 05, 2025

Vol.51 No.32

Clinical Roundup

Cannabis use disorder triples risk of oral cancer, UCSD study finds

Individuals with cannabis use disorder are more than three times more likely to develop oral cancer within five years compared to those without CUD, a researcher at the University of California San Diego School of Medicine found.

August 01, 2025

Vol.51 No.30

Diane Simeone begins work as director of Moores Cancer Center on April 1

YOU MAY BE INTERESTED IN

Project Purple announces research grant to sustain pancreatic cancer studies that have been disrupted by federal funding policy changes

Oral microbes linked to increased risk of pancreatic cancer

Researchers identify key enzyme that pancreatic cancer cells need to obtain vital metabolic nutrients

Checkpoint therapy breakthrough sparks new vaccine

Off-the-shelf cancer vaccine elicits strong immune response in patients with pancreatic and colorectal cancer

Cannabis use disorder triples risk of oral cancer, UCSD study finds

Renew today!

Subscriber content

Never miss an issue!

Login